Drug Shortage Report for MEZERA
| Report ID | 68853 |
| Drug Identification Number | 02474018 |
| Brand name | MEZERA |
| Common or Proper name | Mezera |
| Company Name | AVIR PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | MESALAZINE |
| Strength(s) | 1G |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL |
| Packaging size | 30 |
| ATC code | A07EC |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-12-06 |
| Actual start date | 2018-12-06 |
| Estimated end date | 2018-12-14 |
| Actual end date | 2018-12-20 |
| Shortage status | Resolved |
| Updated date | 2018-12-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-12-21 | English | Compare |
| v6 | 2018-12-20 | French | Compare |
| v5 | 2018-12-20 | English | Compare |
| v4 | 2018-12-07 | English | Compare |
| v3 | 2018-12-06 | French | Compare |
| v2 | 2018-12-06 | English | Compare |
| v1 | 2018-12-06 | English | Compare |
Showing 1 to 7 of 7